Pharmacogenetics & Pharmacogenomics

Pharmacogenetics and pharmacogenomics (pgx) are rapidly growing fields that aim to elucidate the genetic basis for the interindividual differences in drug response. Here is the latest research on pharmacogenetics and pharmacogenomics.

February 24, 2021

Developing synergistic drug combinations to restore antibiotic sensitivity in drug-resistant Mycobacterium tuberculosis.

Antimicrobial Agents and Chemotherapy
Charles OmolloDigby F Warner
February 24, 2021

Stakeholder views on opportunistic genomic screening in the Netherlands: a qualitative study.

European Journal of Human Genetics : EJHG
Anke WoudstraGuido de Wert
February 24, 2021

Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms.

European Journal of Drug Metabolism and Pharmacokinetics
Akitomo YokokawaHiromi Shibasaki
February 24, 2021

Cyclic vomiting syndrome: A narrative review and guide to management.

Katja Kovacic, B U K Li
February 24, 2021

Heritability of Ethanol Consumption and Pharmacokinetics in a Genetically Diverse Panel of Collaborative Cross Mouse Strains and Their Inbred Founders.

Alcoholism, Clinical and Experimental Research
Jared R BagleyJames D Jentsch
February 24, 2021

Welcome to the 22nd volume of Pharmacogenomics.

Sarah Jones
February 24, 2021

Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events.

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Sonam N ShahDavid W Bates
February 24, 2021

Pregnancy from mosaic embryo transfer: genetic counseling considerations.

Current Opinion in Obstetrics & Gynecology
Kelly ChenAllison Boyd
February 24, 2021

Inhibition of HSP90 causes morphological variation in the invasive ant Cardiocondyla obscurior.

Journal of Experimental Zoology. Part B, Molecular and Developmental Evolution
Lukas SchraderJürgen Gadau
February 22, 2021

Biological safety ofSyagrus coronata(Mart.) Becc. fixed oil: cytotoxicity, acute oral toxicity, and genotoxicity studies.

Journal of Ethnopharmacology
Talita Giselly Dos Santos SouzaCristiano Aparecido Chagas
February 22, 2021

Inhibition of mitochondrial complex III induces differentiation in acute myeloid leukemia.

Biochemical and Biophysical Research Communications
Youping ZhangBiao Jiang
February 23, 2021

Pharmacogenetics of sulfonylurea: Presence of CYP2C9*2, CYP2C9*3 and a novel allele, CYP2C9*61, in Type 2 diabetes patients under sulfonylurea therapy.

Pakistan Journal of Pharmaceutical Sciences
Sumaira Deen MuhammadAkhter Ali Balooch
February 23, 2021

A Gender Perspective of Addictive Disorders.

Current Addiction Reports
Francina FonsecaMarta Torrens
February 23, 2021
Open Access

Therapeutic Assessment of Targeting ASNS Combined with l-Asparaginase Treatment in Solid Tumors and Investigation of Resistance Mechanisms.

ACS Pharmacology & Translational Science
Verena ApfelGiorgio G Galli

Sign up to follow this feed and discover related papers.

Related Feeds

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Alzheimer's Disease: RNA Sequencing

RNA sequencing studies have shed light on the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). This feed follows papers using RNA sequencing technologies in Alzheimer's research.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2021 Meta ULC. All rights reserved